Improvements in Health-Related Quality of Life and Psychological Symptoms in Patients With Severe Alopecia Areata Achieving Scalp Hair Regrowth: Results From Two Randomized Controlled Trials
September 2023
in “
Journal of the American Academy of Dermatology
”
TLDR Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.
The document reports on two phase 3 randomized controlled trials (BRAVE-AA1/2) that evaluated the efficacy of Baricitinib in patients with severe alopecia areata (AA). The trials demonstrated that Baricitinib significantly improved scalp hair regrowth. Additionally, these improvements were associated with enhanced health-related quality of life (HRQoL) and reduced psychological symptoms in the patients. The study underscores the importance of addressing both physical and psychological aspects in the treatment of severe AA. The research was fully sponsored by Eli Lilly and Company.